Boothbay Fund Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $81.8K | Sell |
|
|||||
|
2024
Q4 | $279K | Buy |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $425K | Sell |
|
|||||
|
2023
Q1 | $497K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $337K | Sell |
|
|||||
|
2021
Q1 | $529K | Sell |
|
|||||
|
2020
Q4 | $333K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $13K | Buy |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $535K | Buy |
|
|||||
|
2017
Q2 | $350K | Sell |
|
|||||
|
2017
Q1 | $514K | Buy |
|
|||||
|
2016
Q4 | $264 | Buy |
|